Natraemia, natriuresis, inhibitors of sodium transport and high blood pressure;Natrémie, natriurèse, inhibiteurs du transport de sodium et hypertension artérielle

Nephrologie et Therapeutique

Volumn 3, Issue 7, 2007, Pages 433-436

  de Wardener, Hugh ^a  

^a NONE   (United Kingdom)

Author keywords

Experimental hypertension; High blood pressure; Sodium; Sodium transport inhibitors

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DEOXYCORTICOSTERONE; DIGOXIN; GLUCOSE 6 PHOSPHATE; NITRIC OXIDE SYNTHASE INHIBITOR; OUABAIN; SODIUM; SODIUM CHLORIDE; VASOPRESSIN;

ARTERY CLAMP; BLOOD VESSEL TONE; DOG; EDITORIAL; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; KIDNEY CORTEX; NATRIURESIS; NONHUMAN; SODIUM BLOOD LEVEL; SODIUM EXCRETION; SODIUM TRANSPORT; SODIUM URINE LEVEL;

ANIMALS; BIOLOGICAL FACTORS; BIOLOGICAL TRANSPORT, ACTIVE; DOGS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; HYPOTHALAMUS; MODELS, BIOLOGICAL; NATRIURESIS; NATRIURETIC PEPTIDES; RATS; SODIUM; SODIUM, DIETARY; SODIUM-POTASSIUM-EXCHANGING ATPASE; WATER-ELECTROLYTE BALANCE;

EID: 36448941521     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2007.06.015     Document Type: Editorial

References (25)

1. Relman A.S., and Schwartz W.B. The effect of DOCA on electrolyte balance and its relation to sodium chloride intake. Yale J. Biol. Med. 24 (1952) 540-558
2. Smith H.W. Sait and water volume receptors: an exercise in physiologie apologetics. Am. J. Med. 23 (1957) 623-652
3. de Wardener H.E., Mills I.H., Clapham W.F., and Hayter C.J. Studies on the efferent mechanisms of the sodium diuresis which follows the administration of IV saline in the dog. Clin. Sci. 21 (1961) 249-258
4. Bahlam J., McDonald S.J., Ventom M.G., and de Wardener H.E. The effect on urinary sodium of volume expansion without changing the composition of blood in the dog. Clin. Sci. 32 (1967) 403-413
5. Nutbourne D.M., Howse J.D., Schrier R.W., Talner L.B., Ventom M.G., Verroust P.G., et al. The effect of expending the blood volume on a dog on the short circuit current across an isolated frog skin incorporated in the dog circulation. Clin. Sci. 38 (1970) 629-648
6. Clarkson E.M., Talner L.N., and de Wardener H.E. The effect of plasma from blood expanded dogs on sodium, potassium and PAH transport of renal tubules fragments. Clin. Sci. 38 (1970) 617-627
7. de Wardener H.E., and Clarkson E.M. The natriuretic hormone: recent developments. Clin. Sci. 63 (1982) 415-420
8. de Bold A.J. Atrial natriuretic factor of the rat heart. Studies on isolation-properties. Proc. Soc. Exp. Biol. Med. 170 (1982) 133-138
9. Dahl L.K., Knudsen K.D., and Iwai J. Humoral transmision of hypertension. Evidence from parabiosis. Circ. Res. 24 Suppl (1969) 21-33
10. Haddy F.J., and Overbeck H.W. The rôle of humoral agents in volume expanded hypertension. Life Sci. 19 (1975) 935-947
11. Poston L., Sewell R.B., Wilkinson S.P., Richardson P.J., Williams R., Clarkson E.M., et al. Evidence for a circulating sodium transport inhibitor in essential hypertension. BMJ 282 (1981) 847-849
12. Fenton S., Clarkson E.M., MacGregor G.A., Alghband-Zadeh J., and de Wardener H.E. An assay of the capacity of biological fluids to stimulate renal G6PD activity in vitro as a marker of their ability to inhibit sodium-potassium dependent adenosine triphosphatase (Na-K-ATPase) activity. J. Endocrinol. 94 (1982) 99-110
13. de Wardener H.E., and MacGregor G.A. The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension. Medicine 62 (1983) 310-325
14. Blaustein M.P. Sodium ions, calcium ions, blood pressure regulation and hypertension. A reassessment and a hypothesis. Am. J. Physiol. 232 (1977) C132-C173
15. Hamlyn J.M., Harris D.W., and Ludens J.H. Digitalis-like activity in human plasma. Biol. Chem. 264 (1989) 7395-7404
16. Tymiak A.A., Norman J.A., Bolgar M., Lee H., Parker W.L., Lo L.C., et al. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc. Natl. Acad. Sci. USA 90 (1993) 8189-8193
17. Morris H.R., Etienne T., Panico M., Tippins J.R., Alaghband-Zadeh J., Holland S.M., et al. Hypothalamic hypertensive factor. An inhibitor of nitric oxide synthase activity. Hypertension 30 (1987) 1493-1498
18. Nickenig G., Strehlow K., Roeling J., Zolk O., Knorr A., and Bohm M. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension 31 (1998) 1272-1277
19. Leenen F.H., Rusika M., and Huang B.S. Brain and sait sensitive hypertension. Curr. Hypertens. Rep. 4 (2002) 129-135
20. Huang B.S., Van Vliet B.N., and Leenen F.H. Increases in CSF(Na) precede the increases in blood pressure in Dahl S rats and SHR on a high salt diet. Am. J. Physiol. 287 (2004) H1160-H1166 (Circ Physiol)
21. Fang Z., Carlson S.H., Peng N., and Wyss J.M. Circadiam rythm of plasma sodium is disrupted in spontaneously hypertensive rats fed a high NaCl diet. Am. J. Physiol. 278 (2000) R1490-R1496
22. de Wardener H.E., and MacGregor G.A. Plasma sodium and hypertension. Kidney Int. 66 (2004) 2454-2466
23. Komiya I., Yamada T., Takasu N., Asawa T., Akamine H., Yagi N., et al. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone System. J. Hypertens. 15 (1997) 65-72
24. Wannamethee G., Whincuo P.H., Shaper A.G., and Lever A.F. Serum sodium concentration and risk of stroke in middle aged mâles. J. Hypertens. 12 (1994) 971-979
25. He F.J., Markandu N.D., Sagnella G.A., de Wardener H.E., and MacGregor G.A. Plasma sodium. Ignored and underestimated. Hypertension 45 (2005) 98-102